Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 09:18 am Sale | 2023-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | Avoro Capital Advisors LLC | 0 0.000% | -3,060,000 (Position Closed) | Filing History |
| 2024-02-14 09:17 am Purchase | 2023-12-31 | 13G | Ascendis Pharma A/S ASND | Avoro Capital Advisors LLC | 3,755,555 6.500% | 655,555 (+21.15%) | Filing History |
| 2024-02-14 09:15 am Sale | 2023-12-31 | 13G | Kymera Therapeutics, Inc. KYMR | Avoro Capital Advisors LLC | 3,775,000 6.800% | -75,000 (-1.95%) | Filing History |
| 2024-02-14 09:14 am Purchase | 2023-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE | Avoro Capital Advisors LLC | 4,535,000 9.100% | 210,000 (+4.86%) | Filing History |
| 2024-02-14 09:13 am Sale | 2023-12-31 | 13G | Mirati Therapeutics, Inc. MRTX | Avoro Capital Advisors LLC | 4,886,840 7.000% | -668,715 (-12.04%) | Filing History |
| 2024-02-14 09:12 am Purchase | 2023-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE | Avoro Capital Advisors LLC | 5,666,666 7.700% | 766,666 (+15.65%) | Filing History |
| 2024-02-14 09:10 am Purchase | 2023-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA | Avoro Capital Advisors LLC | 658,333 9.990% | 658,333 (New Position) | Filing History |
| 2024-02-14 09:09 am Purchase | 2023-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY | Avoro Capital Advisors LLC | 16,337,739 9.990% | 3,537,739 (+27.64%) | Filing History |
| 2024-02-14 09:08 am Purchase | 2023-12-31 | 13G | Spyre Therapeutics, Inc. SYRE | Avoro Capital Advisors LLC | 2,125,597 5.900% | 2,125,597 (New Position) | Filing History |
| 2024-02-14 09:07 am Purchase | 2023-12-31 | 13G | Structure Therapeutics Inc. GPCR | Avoro Capital Advisors LLC | 6,999,999 5.000% | 6,999,999 (New Position) | Filing History |
| 2024-02-14 09:05 am Sale | 2023-12-31 | 13G | United Therapeutics Corporation UTHR | Avoro Capital Advisors LLC | 2,858,888 6.100% | -6,112 (-0.21%) | Filing History |
| 2024-02-14 09:04 am Unchanged | 2023-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Avoro Capital Advisors LLC | 3,150,000 5.800% | 0 (Unchanged) | Filing History |
| 2024-02-14 09:02 am Purchase | 2023-12-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | Avoro Capital Advisors LLC | 13,050,000 6.400% | 13,050,000 (New Position) | Filing History |
| 2024-02-14 09:00 am Sale | 2023-12-31 | 13G | IO Biotech, Inc. IOBT | Avoro Capital Advisors LLC | 0 0.000% | -2,055,883 (Position Closed) | Filing History |
| 2023-02-14 09:41 am Sale | 2022-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE | Avoro Capital Advisors LLC | 4,900,000 7.800% | -85,000 (-1.71%) | Filing History |
| 2023-02-14 09:40 am Purchase | 2022-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE | Avoro Capital Advisors LLC | 4,325,000 8.900% | 1,013,566 (+30.61%) | Filing History |
| 2023-02-14 09:38 am Purchase | 2022-12-31 | 13G | Mersana Therapeutics, Inc. MRSN | Avoro Capital Advisors LLC | 302,000 7.600% | 30,000 (+11.03%) | Filing History |
| 2023-02-14 09:37 am Sale | 2022-12-31 | 13G | IVERIC bio, Inc. ISEE | Avoro Capital Advisors LLC | 6,750,000 4.960% | -500,000 (-6.90%) | Filing History |
| 2023-02-14 09:37 am Purchase | 2022-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL | Avoro Capital Advisors LLC | 1,660,000 9.700% | 235,000 (+16.49%) | Filing History |
| 2023-02-14 09:37 am Purchase | 2022-12-31 | 13G | Kymera Therapeutics, Inc. KYMR | Avoro Capital Advisors LLC | 3,850,000 7.000% | 3,850,000 (New Position) | Filing History |